COMPARATIVE PROGNOSTIC VALUE OF THE PNEUMONIA SEVERITY INDEX, CURB-65 AND HAEMATOLOGICAL RATIOS (NLR, MLR, PLR) FOR PREDICTING IN-HOSPITAL MORTALITY IN COMMUNITY-ACQUIRED PNEUMONIA
Main Article Content
Keywords
community-acquired pneumonia; pneumonia severity index; CURB-65; neutrophil-to-lymphocyte ratio; in-hospital mortality; prognosis
Abstract
Background: Rapid, reliable risk stratification is central to the management of community-acquired pneumonia (CAP). The pneumonia severity index (PSI) and the CURB-65 score are well validated, but they are time-consuming or require laboratory data that may not be immediately available. Inexpensive haematological ratios derived from a routine complete blood count, the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) and platelet-to-lymphocyte ratio (PLR), have been proposed as surrogate prognostic markers. We compared their performance against PSI and CURB-65 for predicting in-hospital mortality.
Methods: We conducted a retrospective observational cohort study of adults admitted with CAP to POF Hospital, Wah Cantt, between 1 April and 15 July 2024. Demographic, clinical and admission complete-blood-count data were retrieved from electronic records. PSI, CURB-65 and the three ratios were calculated for each patient. Survivors and non-survivors were compared with the Mann–Whitney U test; discrimination for in-hospital mortality was assessed with the area under the receiver-operating-characteristic curve (AUC), AUCs were compared with the DeLong test, and optimal thresholds were derived using the Youden index.
Results: Of 150 admission records, 143 unique patients were analysed (median age 68 years; 62% ≥ 65 years), of whom 121 had a complete admission blood count permitting ratio calculation. In-hospital mortality was 7.0% (10/143). PSI (AUC 0.88, 95% CI 0.75–0.96) and CURB-65 (AUC 0.84, 95% CI 0.72–0.94) discriminated mortality well, and both scores together with the National Early Warning Score were markedly higher in non-survivors (all p ≤ 0.001). In contrast, NLR (AUC 0.44), MLR (AUC 0.52) and PLR (AUC 0.39) showed no discriminatory ability; both clinical scores out-performed every ratio on DeLong testing (all p ≤ 0.005), and the ratios correlated only weakly and non-significantly with PSI and CURB-65 (all |ρ| < 0.08).
Conclusions: In this single-centre cohort, PSI and CURB-65 substantially outperformed the haematological ratios, which carried no independent prognostic value for in-hospital mortality. NLR, MLR and PLR should not replace established severity scores, although their low cost may warrant evaluation as adjuncts in adequately powered, multicentre studies.
References
2. Regunath H, Oba Y. Community-Acquired Pneumonia. In: StatPearls. Treasure Island (FL): StatPearls Publishing; updated 26 Jan 2024.
3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
4. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382.
5. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official ATS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200(7):e45–e67.
6. Al Hussain S, Kurdi A, Abutheraa N, AlDawsari A, Sneddon J, Godman B, et al. Validity of pneumonia severity assessment scores in Africa and South Asia: a systematic review and meta-analysis. Healthcare (Basel). 2021;9(9):1202.
7. Zaki HA, Hamdi Alkahlout B, Shaban E, Mohamed EH, Basharat K, Elsayed WAE, et al. The battle of the pneumonia predictors: a comprehensive meta-analysis comparing the pneumonia severity index (PSI) and the CURB-65 score in predicting mortality and the need for ICU support. Cureus. 2023;15(7):e42672.
8. Noguchi S, Katsurada M, Yatera K, Nakagawa N, Xu D, Fukuda Y, et al. Utility of pneumonia severity assessment tools for mortality prediction in healthcare-associated pneumonia: a systematic review and meta-analysis. Sci Rep. 2024;14(1):12964.
9. Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.
10. Sharma Y, Thompson C, Zinellu A, Shahi R, Horwood C, Mangoni AA. The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumonia. Clin Med (Lond). 2025;25(1):100278.
11. Alzoubi O, Khanfar A. Association between neutrophil to lymphocyte ratio and mortality among community acquired pneumonia patients: a meta-analysis. Monaldi Arch Chest Dis. 2021;92(3):2050.
12. Kuikel S, Pathak N, Poudel S, Thapa S, Bhattarai SL, Chaudhary G, et al. Neutrophil-lymphocyte ratio as a predictor of adverse outcome in patients with community-acquired pneumonia: a systematic review. Health Sci Rep. 2022;5(3):e630.
13. Yang L, Gao C, Li F, Li L, Xu Y, Wang M, et al. Monocyte-to-lymphocyte ratio is associated with 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study. J Intensive Care. 2021;9(1):49.
14. Calis AG, Karaboga B, Uzer F, Kaplan N, Karaca M, Gedik RB, et al. Correlation of pneumonia severity index and CURB-65 score with neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and monocyte/lymphocyte ratio in predicting in-hospital mortality for community-acquired pneumonia: observational study. J Clin Med. 2025;14(3):728.
15. Tekin A, Wireko FW, Gajic O, Odeyemi YE. The neutrophil/lymphocyte ratio and outcomes in hospitalized patients with community-acquired pneumonia: a retrospective cohort study. Biomedicines. 2024;12(2):260.
16. Kumari N, Saifullah N, Jafri S, Ahmed A, Jawad N, Ahmed N. Comparison of NEWS2 and PSI as mortality predictors in patients with community acquired pneumonia. J Pak Med Assoc. 2024;74(6):1156–1159.
17. Arif M, Farhad S, Hussain W, Mustafa G, Panjwani R, Arif S, et al. Evaluating COVID-19 epidemiology, clinical outcomes and neutrophil-to-lymphocyte ratio as a prognosticator of severity of the disease. Pak Biomed J. 2022;5(4):77–81.
18. Gelaidan A, Almaimani M, Alorfi YA, Alqahtani A, Alaklabi NG, Alshamrani SM, et al. Comparative effectiveness of CURB-65 and qSOFA scores in predicting pneumonia outcomes: a systematic review. Cureus. 2024;16(10):e71394.
19. Omair M, Baig MS, Farooqui WA, et al. Relationship of neutrophil lymphocyte ratio, monocyte lymphocyte ratio and neutrophil monocyte ratio with treatment response in pulmonary tuberculosis patients during intensive phase treatment. BMC Infect Dis. 2024;24:615.
20. Ni R, Zhong M, Xie M, Ding Z. Comparative analysis of prognostic scoring systems in predicting severity and outcomes of Omicron variant COVID-19 pneumonia. Front Med (Lausanne). 2024;11:1419690.
21. Huang L, Weng B, Wang M, Weng J, Du X, Ju Y, et al. The improved prediction value of neutrophil-to-lymphocyte ratio to pneumonia severity scores for mortality in older people with community-acquired pneumonia. BMC Geriatr. 2025;25:485.
22. Lv C, Liu S, Yan Y, Ye Y, Gao Y, Zhou M. Improved prediction value of the CURB-65 score combined with the platelet-to-lymphocyte ratio for mortality in emergency department patients with severe community-acquired pneumonia. Front Med (Lausanne). 2026;13:1836427.
23. Pan J, Guo T, Kong H, Bu W, Shao M, Geng Z. Prediction of mortality risk in patients with severe community-acquired pneumonia in the intensive care unit using machine learning. Sci Rep. 2025;15(1):1566.
24. Prasetyo NE, Satoto B, Handoyo T. The relevance of chest X-ray radiologic severity index and CURB-65 score with the death event in hospitalized patients with COVID-19 pneumonia. Egypt J Radiol Nucl Med. 2022;53(1):177.
25. Hancı P, Temel E, Bilir F, Kaya BS. Lactate to albumin ratio as a determinant of intensive care unit admission and mortality in hospitalized patients with community-acquired pneumonia. BMC Pulm Med. 2025;25(1):224.

